IndiaÃ¢â‚¬â„¢s Trade in Drugs and Pharmaceuticals : Emerging Trends, Opportunities and Challenges
AbstractIt was argued in the context economic reforms in pharmaceuticals sector, particularly in the context of changing patent regime, that growth in exports would be restricted, imports would get a fillip and balance of trade would be adversely affected. The paper looks into the recent experience in exports and imports of drugs and pharmaceutical products. It is found that there is a tremendous growth in the exports. The focus of exports has shifted from intermediates and bulk drugs to formulations. The expiry of patents on drugs worth billions of dollars in the near future, would provide a big opportunity for Indian generic producers. However, the expansion of formulation exports is increasingly facing challenges from various corners-increasing application of non tariff barriers by importing countries, authorised Indian generics being targeted by global anti-counterfeit drive and competition from China. Import of formulations did not increase as has been anticipated. Paper also finds that there is a negative and growing trade balance, owing to the import of intermediates and bulk drugs. The industry is now increasingly adopting the strategy of importing intermediates and bulk drugs and processing them into formulations. The removal of ratio parameter linking the production of intermediates and bulk drugs to the production of formulations has eliminated compulsions on the indigenous production of intermediates and bulk drugs.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by East Asian Bureau of Economic Research in its series Trade Working Papers with number 22783.
Date of creation: Jan 2009
Date of revision:
Contact details of provider:
Postal: JG Crawford Building #13, Asia Pacific School of Economics and Government, Australian National University, ACT 0200
Web page: http://www.eaber.org
More information through EDIRC
pharmaceutical sector; trade; India; intelluctual property;
Find related papers by JEL classification:
- F10 - International Economics - - Trade - - - General
- I10 - Health, Education, and Welfare - - Health - - - General
- O34 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Intellectual Property and Intellectual Capital
You can help add them by filling out this form.
reading list or among the top items on IDEAS.Access and download statisticsgeneral information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Shiro Armstrong).
If references are entirely missing, you can add them using this form.